
Loading, please wait...

Loading, please wait...

Managing patient anxiety effectively is a cornerstone of successful dental surgical practice. Dentists frequently utilize various pharmacological protocols to ensure patient comfort during complex procedures. Specifically, researchers recently conducted a randomized trial to evaluate the efficacy of midazolam-promethazine oral sedation compared to midazolam monotherapy. This study aimed to clarify if combining these agents provides a clinical advantage for anxious patients undergoing third molar surgery.
The randomized, double-blind, split-mouth study included eighteen patients requiring bilateral mandibular third molar extractions. During one session, patients received 15mg of midazolam alone. In a separate session, they received a combination of 15mg of midazolam and 25mg of promethazine. Surprisingly, the depth of sedation, measured by the Ramsay scale, showed no statistically significant difference between the two protocols. Similarly, both groups reported comparable anxiety levels based on the Corah scale throughout the procedures. Consequently, these results suggest that midazolam alone remains a highly effective standard for moderate sedation.
Beyond sedation depth and anxiety control, the trial monitored crucial physiological parameters. Researchers observed that Group B experienced slight variations in heart rate and oxygen saturation at specific time intervals. However, these changes remained well within safe clinical limits and did not lead to adverse complications. Because the clinical benefits of the combination were not superior, the study highlights that midazolam monotherapy might be sufficient for most routine extractions. Therefore, clinicians should weigh the necessity of additional agents against the potential for altered physiological responses.
According to this randomized clinical trial, the combination of midazolam and promethazine does not significantly improve the depth of sedation or reduce patient anxiety compared to using midazolam alone for third molar extractions.
The combination therapy showed minor, statistically significant fluctuations in heart rate and oxygen saturation. Nevertheless, these changes were not clinically dangerous, and both sedation protocols were considered safe for healthy patients in this study.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A randomized trial comparing oral midazolam and midazolam-promethazine for third molar surgery finds no significant difference in sedation depth or anxiety....
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today